Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $6.3B | SEC | |
| Buy | $7.8B | SEC | |
| Buy | $1.2B | SEC | |
| Buy | $1.2B | SEC | |
| Buy | $304M | SEC | |
| Buy | $279M | SEC | |
| Buy | $2.2B | SEC | |
| Buy | $1.3B | SEC | |
| Buy | $30B | SEC | |
| Buy | $27.5B | SEC | |
| Buy | $17.5B | SEC | |
| Buy | $1.2B | SEC | |
| Buy | $17.5B | SEC | |
| Buy | $7.2B | SEC | |
| Buy | $8.2B | SEC | |
| Buy | $9.1B | SEC | |
| Buy | $208M | SEC | |
| Buy | $5.7B | SEC | |
| Buy | $9.7B | SEC | |
| Buy | $10.1B | SEC | |
| Buy | $9.1B | SEC | |
| Buy | $319.1M | SEC | |
| Buy | $8.2B | SEC | |
| Buy | $8.2B | SEC | |
| Buy | $8.2B | SEC |